Research institute
The Christiana Care Health System’s Gene Editing Institute, based in Wilmington, Del., is pulling together a preliminary investigational new drug application (IND) for the U.S. Food and Drug Administration (FDA).
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
The employees were terminated over allegations of industrial espionage on behalf of the Chinese government. MD Anderson ought to quell concerns of racial profiling following the firings.
An open-label, multi-cohort Phase II trial, led by investigators at The University of Texas MD Anderson Cancer Center, reports that treatment with the drug tagraxofusp resulted in high response rates in patients with blastic plasmacytoid dendritic cell neoplasm, a rare but highly aggressive – and often fatal bone marrow and blood disorder – for which there are no existing approved therapies.
Singapore scientists are developing a single test that can detect and differentiate multiple mosquito-borne viruses and their types
Scientists from the Agency for Science, Technology and Research’s (A*STAR), Genome Institute of Singapore (GIS), together with scientists from Duke-NUS Medical School and A*STAR’s Bioinformatics Institute (BII), have mapped out the structures of four dengue and four Zika viruses.
Steps have been taken to safeguard the cancer center, including development of a cutting-edge approach to Enterprise Risk Management.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
St. Jude Children’s Research Hospital published data from its Phase I/II clinical trial of its gene therapy for SXCID or SCID-X1, also dubbed “bubble boy disease.” The research was published in the New England Journal of Medicine.
Study finds that resistant cells become vulnerable to MD Anderson-developed targeted therapy
PRESS RELEASES